Trualt Bioenergy Limited has scheduled a group meeting with analysts and institutional investors on June 12, 2026, to discuss its performance and outlook. The interaction will take place virtually as part of the InsightX 2026-Choice Virtual Conference, organized by Choice Equity Broking Pvt. Ltd. The session is set to occur from 11:00 A.M. to 12:00 P.M. (IST).

The company stated that the discussion will be based exclusively on publicly available information. No unpublished price-sensitive information will be shared during the meeting. This disclosure was made in accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The following table outlines the specific schedule and particulars for the investor interaction:

Trualt Bioenergy noted that the investor meetings are subject to last-minute changes due to exigencies on the part of the investors or the company. The information regarding the meeting is also available on the company's official website.

TruAlt Bioenergy Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone and consolidated financial results at its meeting held on May 22, 2026. The company reported a consolidated Profit After Tax (PAT) of ₹96.86 crore for the fiscal year 2025-26, while revenue from operations for the year stood at ₹1,72,750.66 crore. For the quarter ended March 31, 2026, the company recorded a net profit of ₹609.50 crore compared to ₹1,116.94 crore in the same quarter of the previous year, while revenue came in at ₹595.52 crore against ₹906.99 crore year-on-year, reflecting a notable decline across key metrics. The statutory auditors, M/s N. M. Raiji & Co., issued an unmodified opinion on the financial results.

Financial Performance

The company's full-year operational metrics showed variations compared to the previous year. The total comprehensive income for the year was ₹9,710.18 crore, with Earnings per Share (EPS) reported at ₹12.30 on a basic and diluted basis. Finance costs for the year increased to ₹16,002.41 crore from ₹14,361.10 crore in the previous year.

The following table summarises the full-year consolidated financial performance:

Q4 Performance Highlights

The quarter ended March 31, 2026 reflected a marked year-on-year contraction across key financial indicators. Net profit stood at ₹609.50 crore compared to ₹1,116.94 crore in the corresponding quarter of the prior year. Revenue declined to ₹595.52 crore from ₹906.99 crore year-on-year. Despite the revenue pressure, EBITDA margin improved to 19.94% from 17.00% year-on-year, even as absolute EBITDA contracted to ₹119.47 crore from ₹153.44 crore in the same period last year.

The key Q4 metrics are summarised below:

Operational Challenges

The company faced significant headwinds during the quarter due to a sharp reduction in ethanol lifting by Oil Marketing Companies (OMCs). Despite adequate raw material availability and fully operational capacities across its 2,000 KLPD ethanol platform, offtake remained materially below requirements. Performance was further impacted by delays in executing a pending allocation of approximately 15 crore litres following an order from the Hon'ble Karnataka High Court. This pending quantity represents an estimated revenue potential of nearly ₹1,062 crore.

Corporate Developments

During the year, TruAlt Bioenergy developed dual-feed capabilities to mitigate seasonality in the ethanol business, with dual-feed capacities installed at Unit 1, Unit 2, and Unit 4. Sumitomo Corporation acquired a 49% equity interest in TruAlt Gas Private Limited, a subsidiary, in April 2026. The company also entered into an agreement with Honeywell to deploy Ethanol-to-Jet (ETJ) process technology for a sustainable aviation fuel production facility with an envisaged capacity of 80,000 tonnes per annum. The Board approved the appointment of M/s ZADN and Associates LLP as Internal Auditors and M/s R. Nanabhoy & Co. as Cost Auditors for the financial year 2026-27.